Adoptive T Cell Therapy investors in China.

Adoptive T Cell Therapy investors in China

Fliar publishes 1 investor page for Adoptive T Cell Therapy in China. That is 1 investor list. The list with the most capital behind it is Adoptive T Cell Therapy investors in Shanghai ($6.4B across the rounds it covers).

This is the only one we publish so far. For a wider view, see all Adoptive T Cell Therapy investor pages or everything in China.

Related sectors: Cell Therapy, Gene Therapy, Antibody Based Immunotherapy, Cancer Immunotherapy, Immunology and Genomics for Drug Discovery.